Twelve people with chikungunya have reportedly died in Delhi in recent days, as the city grapples with an outbreak of the mosquito-borne illness. The WHO article linked to below contains advice on how to minimise risk of infection.

From the BBC

Why Delhi is gripped by chikungunya fears

More than 1,000 cases of the illness have been registered in the city.

Local media have reported that 10 people in the city have also died of chikungunya-related complications, although this is yet to be officially confirmed. The illness is largely non-lethal although the WHO says that in older people it can contribute to the cause of death.

India’s health minister JP Nadda told reporters that the government was investigating to see if the virus could be linked to the deaths, as many of those who died were already suffering from other illnesses such as kidney disease and high blood pressure.

Please click here to read more.

From the World Health Organisation


Chikungunya is characterized by an abrupt onset of fever frequently accompanied by joint pain. Other common signs and symptoms include muscle pain, headache, nausea, fatigue and rash. The joint pain is often very debilitating, but usually lasts for a few days or may be prolonged to weeks. Hence the virus can cause acute, subacute or chronic disease.

Most patients recover fully, but in some cases joint pain may persist for several months, or even years. Occasional cases of eye, neurological and heart complications have been reported, as well as gastrointestinal complaints. Serious complications are not common, but in older people, the disease can contribute to the cause of death. Often symptoms in infected individuals are mild and the infection may go unrecognized, or be misdiagnosed in areas where dengue occurs.

Please click here to read more.


Like what you read? Sign up here for our free Daily Updates. We also send out a Weekly K+R Update, bundling together all the K+R news of the week. (Same form – options at the end.)
 Other ways to stay up to date:

Follow and subscribe!

Follow us on Twitter, LinkedIn, and Facebook. You can also subscribe to our free newsletters - the Daily Updates and the Weekly K+R Update.